IL86476A - A method for producing a polypeptide having human cysteine C activity and AND sequence for performing this method - Google Patents

A method for producing a polypeptide having human cysteine C activity and AND sequence for performing this method

Info

Publication number
IL86476A
IL86476A IL8647688A IL8647688A IL86476A IL 86476 A IL86476 A IL 86476A IL 8647688 A IL8647688 A IL 8647688A IL 8647688 A IL8647688 A IL 8647688A IL 86476 A IL86476 A IL 86476A
Authority
IL
Israel
Prior art keywords
cystatin
ala
des
leu
gcc
Prior art date
Application number
IL8647688A
Other languages
English (en)
Hebrew (he)
Other versions
IL86476A0 (en
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL86476A0 publication Critical patent/IL86476A0/xx
Publication of IL86476A publication Critical patent/IL86476A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL8647688A 1987-05-22 1988-05-23 A method for producing a polypeptide having human cysteine C activity and AND sequence for performing this method IL86476A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK260987A DK260987D0 (da) 1987-05-22 1987-05-22 Fremgangsmaade til fremstilling af et humant protein samt dna-sekvens til anvendelse ved udoevelse af fremgangsmaaden

Publications (2)

Publication Number Publication Date
IL86476A0 IL86476A0 (en) 1988-11-15
IL86476A true IL86476A (en) 1994-01-25

Family

ID=8113675

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8647688A IL86476A (en) 1987-05-22 1988-05-23 A method for producing a polypeptide having human cysteine C activity and AND sequence for performing this method

Country Status (12)

Country Link
EP (1) EP0362259B1 (de)
JP (1) JP3011274B2 (de)
AT (1) ATE135049T1 (de)
AU (1) AU619750B2 (de)
CA (1) CA1340862C (de)
DE (1) DE3855078T2 (de)
DK (1) DK260987D0 (de)
ES (1) ES2013337A6 (de)
FI (1) FI102191B (de)
IL (1) IL86476A (de)
NO (1) NO301985B1 (de)
WO (1) WO1988009384A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2002820A1 (en) * 1988-11-18 1990-05-18 Kazunori Hanada Pharmaceutical use for cystatins
GB9122051D0 (en) * 1991-10-17 1991-11-27 Univ Nottingham Medicines
GB9403819D0 (en) * 1994-02-28 1994-04-20 Univ Leeds Control of parasites
CA2205356A1 (en) * 1994-11-21 1996-05-30 Peter Edward Urwin Modified proteinase inhibitors
AU738766B2 (en) * 1994-11-21 2001-09-27 University Of Leeds, The Modified proteinase inhibitors
US6011012A (en) 1995-06-05 2000-01-04 Human Genome Sciences, Inc. Human cystatin E
EP0842187A4 (de) * 1995-06-05 2000-04-12 Human Genome Sciences Inc Humancystanin e
WO2000008159A2 (en) * 1998-08-05 2000-02-17 The University Of British Columbia Production and use of modified cystatins
WO2000033791A2 (en) * 1998-12-11 2000-06-15 The Salk Institute For Biological Studies Co-factors for trophic factors, and methods of use thereof
EP1176200A3 (de) 2000-06-20 2005-01-12 Switch Biotech Aktiengesellschaft Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankung oder Wundheilung sowie ihre Verwendung zur Indentifizierung von pharmakologisch aktiven Substanzen
KR20190062611A (ko) * 2012-07-31 2019-06-05 유키지루시 메그밀크 가부시키가이샤 신규 단백질 소재
CN102895658A (zh) * 2012-08-23 2013-01-30 苏州大学附属第一医院 Cystatin C在治疗蛛网膜下腔出血后发生的脑血管痉挛的应用
CN106119286A (zh) * 2016-08-10 2016-11-16 吴江近岸蛋白质科技有限公司 表达载体及其高效表达和制备人胱抑素c蛋白的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C

Also Published As

Publication number Publication date
JP3011274B2 (ja) 2000-02-21
AU1939988A (en) 1988-12-21
FI102191B1 (fi) 1998-10-30
EP0362259B1 (de) 1996-03-06
DE3855078T2 (de) 1996-07-18
DK260987D0 (da) 1987-05-22
DE3855078D1 (de) 1996-04-11
JPH03501201A (ja) 1991-03-22
NO890260D0 (no) 1989-01-20
NO301985B1 (no) 1998-01-05
ATE135049T1 (de) 1996-03-15
ES2013337A6 (es) 1990-05-01
IL86476A0 (en) 1988-11-15
FI895553A0 (fi) 1989-11-21
NO890260L (no) 1989-01-20
WO1988009384A1 (en) 1988-12-01
FI102191B (fi) 1998-10-30
CA1340862C (en) 1999-12-28
AU619750B2 (en) 1992-02-06
EP0362259A1 (de) 1990-04-11

Similar Documents

Publication Publication Date Title
AU657701B2 (en) Interleukin 1beta protease and interleukin 1beta protease inhibitors
EP0362259B1 (de) Verfahren zur herstellung von cystatin-c oder abwandlungen davon und dns-sequenz zur ausführung dieser methode
WO1991015577A1 (en) INTERLEUKIN 1'beta' PROTEASE
EP0511393B1 (de) Hirudinmutante, deren herstellung, antikoagulans, sekretorischer vektor, durch besagten vektor transformierter mikroorganismus und herstellung eines produkts durch besagten mikroorganismus
EP0713495A1 (de) Methoden zur erhöhung der biologischen aktivität von chemokinen
JPH0341095A (ja) 遺伝子操作により産生されたアルツハイマープロテアーゼ阻害因子の相同体、それらの産生のための宿主菌株および発現ベクターおよび薬物としてのそれらの使用
JPS61124392A (ja) 遺伝子組換体の産生する生理活性物質の精製法
US5432264A (en) Recombinant 3-des-OH-cystatin C produced by expression in a procaryotic host cell
WO1998029446A1 (fr) Neuropeptides provenant du scorpion
JPH04500508A (ja) 非グリコシル化　ヒト　インターロイキン―３　組成物
AU661515B2 (en) Polypeptide, DNA fragment encoding the same, drug composition containing the same and process for producing the same
US20090023184A1 (en) Novel Tachykinin Peptides, Precursor Peptides Thereof And Genes Encoding The Same
JPH03284700A (ja) 機能性ポリペプチド
US5972648A (en) Hirudin analogs, methods of manufacture thereof and anticoagulant compositions having these as active ingredients
JP2003047475A (ja) 新規オキシトシン／バソプレシンスーパーファミリーに分類されるペプチドおよびその前駆体ポリペプチドならびにこれらをコードする遺伝子
RU2106408C1 (ru) Аналог гирудина, днк, вектор, способ получения аналога гирудина
EP0625580A1 (de) Neuartige hirudinvariante, ihr herstellungsprozess, und antikoagulant der sie als aktiven wirkstoff enthält
JPH04173798A (ja) ヒルジン変異体，その製造法及び抗凝血剤
JPH04166087A (ja) 新規な蛋白
DK164283B (da) Polypeptid med cystatin c aktivitet, dna-sekvens til udtrykkelse af 3-des-oh-cystatin c eller en modifikation deraf, fremgangsmaade til fremstilling af 3-des-hydroxy-cystatin c eller en modifikation deraf, plasmid og mikroorganisme til udoevelse af fremgangsmaaden og anvendelse af 3-des-oh-cystatin c eller en modifikation deraf til fremstilling af et terapeutisk praeparat
JPH06321989A (ja) 新規ポリペプチド、新規ｄｎａおよび医薬組成物
JPH0859697A (ja) ペプチド並びにそれを含有するプロリルエンドペプチダーゼ阻害剤、機能性食品及び動物用飼料

Legal Events

Date Code Title Description
KB Patent renewed
RH Patent void
KB Patent renewed
KB Patent renewed
EXP Patent expired